ZA200400017B - Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors. - Google Patents

Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors. Download PDF

Info

Publication number
ZA200400017B
ZA200400017B ZA200400017A ZA200400017A ZA200400017B ZA 200400017 B ZA200400017 B ZA 200400017B ZA 200400017 A ZA200400017 A ZA 200400017A ZA 200400017 A ZA200400017 A ZA 200400017A ZA 200400017 B ZA200400017 B ZA 200400017B
Authority
ZA
South Africa
Prior art keywords
solvent
formula
organic solvent
simvastatin
methyl
Prior art date
Application number
ZA200400017A
Other languages
English (en)
Inventor
Thaper Rajesh Kumar
Kumar Saridi Mdhava Dileep
Kumar Yatendra
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of ZA200400017B publication Critical patent/ZA200400017B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/30—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with trihydroxylic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28—Hydrogenated naphthalenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200400017A 2001-06-13 2004-01-05 Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors. ZA200400017B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN659DE2001 2001-06-13

Publications (1)

Publication Number Publication Date
ZA200400017B true ZA200400017B (en) 2004-10-25

Family

ID=11097071

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200400017A ZA200400017B (en) 2001-06-13 2004-01-05 Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors.

Country Status (12)

Country Link
US (1) US6541511B1 (cs)
EP (1) EP1404313A4 (cs)
JP (1) JP2005500282A (cs)
CN (1) CN1535145A (cs)
BR (1) BR0210426A (cs)
CA (1) CA2450617A1 (cs)
CZ (1) CZ200450A3 (cs)
EA (1) EA200400034A1 (cs)
PL (1) PL367885A1 (cs)
SK (1) SK242004A3 (cs)
WO (1) WO2002100323A2 (cs)
ZA (1) ZA200400017B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101126084B1 (ko) * 2008-11-04 2012-03-29 한미홀딩스 주식회사 (3ｓ,4ｓ)-4-((ｒ)-2-(벤질옥시)트라이데실)-3-헥실-2-옥세타논의 제조방법 및 이에 사용되는 중간체
CN102086184A (zh) * 2011-03-03 2011-06-08 上海应用技术学院 5位氟取代的4-羟基-3,4,5,6-四氢-2h-吡喃-2-酮类化合物及其制备方法
WO2014168933A1 (en) 2013-04-08 2014-10-16 Cytodyn Inc. Felinized antibodies and methods of treating retroviral infections in felines
ES2524647B1 (es) * 2013-06-06 2015-09-15 Neuron Bio, S.A. Compuestos neuroprotectores, antiinflamatorios y antiepilépticos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4137322A (en) 1976-11-02 1979-01-30 Sankyo Company Limited ML-236B carboxylic acid derivatives and their use as antihyperlipemic agents
ES493726A0 (es) 1979-07-27 1981-06-16 Sankyo Co Un procedimiento para la preparacion de sales y esteres, de monacolina k utiles como agentes antitlipercolesteremicos.
JPS56142236A (en) 1980-04-08 1981-11-06 Sankyo Co Ltd Ml-236a and mb-530a derivative
US4343814A (en) 1980-11-17 1982-08-10 Merck & Co., Inc. Hypocholesterolemic fermentation products
EP0068038B1 (en) 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4r,6s)-(e)-6-(2-(4'-fluoro-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2h-pyran-2-one, a process for preparing and a pharmaceutical composition containing the same
US4582915A (en) * 1983-10-11 1986-04-15 Merck & Co., Inc. Process for C-methylation of 2-methylbutyrates
US6376683B1 (en) * 2001-06-01 2002-04-23 Council Of Scientific & Industrial Research Process for the preparation of (4R,6S)-4-hydroxy-6-hydroxymethyl-tetrahydropyran-2-one

Also Published As

Publication number Publication date
WO2002100323A3 (en) 2003-09-18
EP1404313A4 (en) 2006-01-18
US6541511B1 (en) 2003-04-01
JP2005500282A (ja) 2005-01-06
WO2002100323A2 (en) 2002-12-19
PL367885A1 (en) 2005-03-07
BR0210426A (pt) 2004-08-17
SK242004A3 (en) 2004-06-08
CZ200450A3 (cs) 2004-05-12
EA200400034A1 (ru) 2004-06-24
CA2450617A1 (en) 2002-12-19
EP1404313A2 (en) 2004-04-07
CN1535145A (zh) 2004-10-06

Similar Documents

Publication Publication Date Title
AU601981B2 (en) Trans- (2-(3 or 4-carboxamido-substituted pyrrol-1-yl) alkyl)-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
EP0323867B1 (en) Novel hmg-coa reductase inhibitors
US4863957A (en) Novel HMG-CoA reductase inhibitors
US4857547A (en) Novel HMG-CoA reductase inhibitors
US6686481B2 (en) Highly purified simvastatin compositions
Lee et al. Structural modification of mevinolin
AU2001282981A1 (en) Highly purified simvastatin compositions
US4857546A (en) Novel HMG-CoA reductase inhibitors
AU606203B2 (en) Novel hmg-coa reductase inhibitors
ZA200400017B (en) Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors.
EP0410409A1 (en) 3,5-Dihydroxypentanoic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
US4665091A (en) Macrocyclic lactone HMG-CoA reductase inhibitors
AU2002304343A1 (en) Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors
US5177104A (en) 6-α-hydroxy derivatives of mevinic acids
JP2004520445A5 (cs)
EP0420266A2 (en) Chromene or thiochromene derivatives, process for preparing the same, intermediate therefor, pharmaceutical compositions containing said derivatives and the use of said derivatives
JPH03173848A (ja) メビン酸誘導体
US5286746A (en) Sulfur-substituted mevinic acid derivatives
Dabak et al. A new method for the synthesis of antihypercholesterolemic agent simvastatin